TEVA
- Teva Pharmaceutical Industries Limited
()
Overview
Company Summary
Teva Pharmaceutical Industries Limited, commonly known as Teva, is a multinational pharmaceutical company headquartered in Israel. It is one of the largest generic drug manufacturers in the world and also develops and markets its own brand-name pharmaceutical products.
Teva's primary focus is on the production and distribution of generic drugs. Generic drugs are identical or bioequivalent versions of brand-name drugs that have lost their patent protection. By manufacturing and selling generic drugs, Teva aims to provide more affordable options for patients and healthcare systems.
In addition to generic drugs, Teva also develops and markets brand-name pharmaceuticals across various therapeutic areas, including central nervous system disorders, respiratory diseases, oncology, and more. Some of the well-known brand-name drugs in the company's portfolio include Copaxone for multiple sclerosis, Azilect for Parkinson's disease, and ProAir and Qvar for respiratory conditions.
Beyond pharmaceuticals, Teva also has a presence in the global over-the-counter (OTC) market. It offers a range of consumer healthcare products, including vitamins, supplements, pain relievers, cough and cold medications, and skincare products.
Teva operates on a global scale, with manufacturing and distribution facilities spread across various countries. The company's products are sold in more than 60 countries, serving patients and healthcare providers worldwide.
Overall, Teva Pharmaceutical Industries Limited plays a significant role in the pharmaceutical industry by producing generic drugs, developing and marketing brand-name pharmaceuticals, as well as providing consumer healthcare products, all with the aim of improving access to cost-effective medications for patients globally.